Melodi Health Announces $10.75 Million in Series A Funding, First Enrollment in Pivotal Clinical Trial Katie Lew · August 29, 2024
August 29, 2024 Melodi Health Announces $10.75 Million in Series A Funding, First Enrollment in Pivotal Clinical TrialGround-breaking investigational product from Melodi Health is designed to reduce post-surgical infections
August 27, 2024 NeuraWorx Partners with Corundum Neuroscience to Initiate Clinical Feasibility Study, Develop Innovative Neurological Disease TreatmentEXCELSIOR, Minn. – Aug. 27, 2024 – PRLog — NeuraWorx Medical Technologies, Inc., a neurotechnology therapeutics company, announced
August 27, 2024 Biocoat Incorporated Secures New Patent for Non-PFAS Inner Diameter CoatingHorsham, PA, [August 27, 2024] – Biocoat Incorporated, a leader in the
News, Press ReleaseIn the Know: Healthcare News for July 22, 2024 Dave TierneyJuly 22, 2024 In the Know: Healthcare News for July 22, 2024
News, Press ReleaseSPR® Therapeutics Unveils Long-term Data on SPRINT® PNS and Initial MONARCH™ Trial Update Dave TierneyJuly 18, 2024 SPR® Therapeutics Unveils Long-term Data on SPRINT® PNS and Initial MONARCH™ Trial Update
News, Press ReleaseMEKanistic Therapeutics Inc.’s First-In-Class Dual EGFR and PI3K Investigational Therapy, MTX-531,Demonstrates Significant Tolerability and Durable Tumor Regressions in Preclinical Cancer Models Dave TierneyJuly 17, 2024 MEKanistic Therapeutics Inc.’s First-In-Class Dual EGFR and PI3K Investigational Therapy, MTX-531,Demonstrates Significant Tolerability and Durable Tumor Regressions in Preclinical Cancer Models
News, Press ReleaseNeuspera Medical Raises $23 Million in Series D Financing Dave TierneyJuly 15, 2024 Neuspera Medical Raises $23 Million in Series D Financing